Actively Recruiting
Evaluation of Pain Treatment After Total Knee Arthroplasty
Led by Vertex Pharmaceuticals Incorporated · Updated on 2026-05-13
60
Participants Needed
2
Research Sites
40 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the study is to characterize opioid use after total knee arthroplasty (TKA).
CONDITIONS
Official Title
Evaluation of Pain Treatment After Total Knee Arthroplasty
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Body mass index (BMI) of greater than or equal to 18.0 to less than or equal to 40.0 kilogram per meter square (kg/m²)
- Scheduled to undergo an elective primary unilateral total knee arthroplasty (TKA) surgery
You will not qualify if you...
- History of previous total knee arthroplasty (TKA) surgery on the same side
- Other protocol defined inclusion/exclusion criteria will apply
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Legent Orthopedic and Spine Hospital
Bellaire, Texas, United States, 77401
Actively Recruiting
2
Memorial Hermann Village Office
Houston, Texas, United States, 77043
Actively Recruiting
Research Team
M
Medical Information
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
NON_RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here